Oxford Nanopore Tech - Director/PDMR Shareholding

Oxford Nanopore Technologies

03/03/2026 07:00

RNS Number : 0202V

Oxford Nanopore Technologies plc

03 March 2026

 

03 March 2026

Oxford Nanopore Technologies plc (the "Company")

Director/PDMR Notification

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

The Company has been notified that, on 2 March 2026, Duncan Tatton-Brown, Chair of the Company and a Person Discharging Managerial Responsibilities, purchased a total of 87,000 ordinary shares in the Company at a price of £1.1550 per share.

This announcement is made pursuant to the Company's obligations under Article 19(3) of the UK Market Abuse Regulation.

Duncan Tatton-Brown - purchase of shares

1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Duncan Tatton-Brown
2
Reason for the notification
a)
Position/status
Chair
b)
Initial/Amendment notification
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Oxford Nanopore Technologies plc
b)
LEI
213800IRWQ2Q6M2CDW55
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of £0.0001 each
GB00BP6S8Z30
b)
Nature of the transaction
Purchase of shares in the Company.
c)
Price(s) and volume(s)
Price(s)
Volume(s)
£1.1550
87,000
d)
Aggregated information
- Aggregated volume
- Aggregated price
87,000 shares
£100,485
e)
Date of the transaction
02 March 2026
f)
Place of the transaction
London Stock Exchange (XLON)

Enquiries:

Investors

ir@nanoporetech.com 

Media 

media@nanoporetech.com

OxfordNanoporeTechnologies@teneo.com      

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
DSHBCGDXLUGDGLD